Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 20359534)

1.

Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia.

Cui M, Wang L, Liang X, Ma X, Liu Y, Yang M, Liu K, Wei X, Zhou Z, Chen YH, Sun W.

Neurobiol Dis. 2010 Aug;39(2):138-47. doi: 10.1016/j.nbd.2010.03.018. Epub 2010 Mar 30.

PMID:
20359534
2.

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling and cell death in the immature central nervous system after hypoxia-ischemia and inflammation.

Kichev A, Rousset CI, Baburamani AA, Levison SW, Wood TL, Gressens P, Thornton C, Hagberg H.

J Biol Chem. 2014 Mar 28;289(13):9430-9. doi: 10.1074/jbc.M113.512350. Epub 2014 Feb 7.

3.

Hypoxia-ischemia upregulates TRAIL and TRAIL receptors in the immature rat brain.

Huang Z, Song L, Wang C, Liu JQ, Chen C.

Dev Neurosci. 2011;33(6):519-30. doi: 10.1159/000334475. Epub 2012 Jan 27.

PMID:
22286051
4.

CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons.

Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, Debatin KM.

J Neurosci. 1999 May 15;19(10):3809-17.

5.

Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.

Jaganathan J, Petit JH, Lazio BE, Singh SK, Chin LS.

Neurosurg Focus. 2002 Sep 15;13(3):ecp1.

PMID:
15844877
6.
7.

Green tea polyphenol (-)-epigallocatechin gallate reduces neuronal cell damage and up-regulation of MMP-9 activity in hippocampal CA1 and CA2 areas following transient global cerebral ischemia.

Park JW, Jang YH, Kim JM, Lee H, Park WK, Lim MB, Chu YK, Lo EH, Lee SR.

J Neurosci Res. 2009 Feb;87(2):567-75. doi: 10.1002/jnr.21847.

PMID:
18752302
8.
9.

Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.

Khan M, Sekhon B, Jatana M, Giri S, Gilg AG, Sekhon C, Singh I, Singh AK.

J Neurosci Res. 2004 May 15;76(4):519-27.

PMID:
15114624
10.

Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits.

Wang Q, Sun AY, Simonyi A, Jensen MD, Shelat PB, Rottinghaus GE, MacDonald RS, Miller DK, Lubahn DE, Weisman GA, Sun GY.

J Neurosci Res. 2005 Oct 1;82(1):138-48.

PMID:
16075466
11.

Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.

Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.

Free Radic Biol Med. 2008 Mar 15;44(6):1055-68. doi: 10.1016/j.freeradbiomed.2007.12.001. Epub 2007 Dec 8.

PMID:
18164688
12.

Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5.

Gasparian ME, Chernyak BV, Dolgikh DA, Yagolovich AV, Popova EN, Sycheva AM, Moshkovskii SA, Kirpichnikov MP.

Apoptosis. 2009 Jun;14(6):778-87. doi: 10.1007/s10495-009-0349-3.

PMID:
19412666
13.

Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia.

Cho JY, Kim IS, Jang YH, Kim AR, Lee SR.

Neurosci Lett. 2006 Sep 1;404(3):330-5. Epub 2006 Jun 27.

PMID:
16806698
14.

Hippocampal CA1 cell loss in a non-human primate model of transient global ischemia: a pilot study.

Hara K, Yasuhara T, Matsukawa N, Maki M, Masuda T, Yu G, Xu L, Tambrallo L, Rodriguez NA, Stern DM, Kawase T, Yamashima T, Buccafusco JJ, Hess DC, Borlongan CV.

Brain Res Bull. 2007 Sep 14;74(1-3):164-71.

PMID:
17683803
15.
16.

DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design.

Tur V, van der Sloot AM, Reis CR, Szegezdi E, Cool RH, Samali A, Serrano L, Quax WJ.

J Biol Chem. 2008 Jul 18;283(29):20560-8. doi: 10.1074/jbc.M800457200. Epub 2008 May 12.

17.

Expression of TRAIL and the death receptors DR4 and DR5 correlates with progression of degeneration in human intervertebral disks.

Bertram H, Nerlich A, Omlor G, Geiger F, Zimmermann G, Fellenberg J.

Mod Pathol. 2009 Jul;22(7):895-905. doi: 10.1038/modpathol.2009.39. Epub 2009 Mar 20.

18.

Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.

Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L, Zhu J.

Neurosurgery. 2009 Sep;65(3):610-24; discussion 624. doi: 10.1227/01.NEU.0000350227.61132.A7.

PMID:
19687708
19.

Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.

Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D.

FEBS J. 2008 Apr;275(8):1925-36. doi: 10.1111/j.1742-4658.2008.06351.x. Epub 2008 Mar 13.

PMID:
18341587
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk